مالطا -
الإنجليزية -
Malta Medicines Authority
beclo-rino 50 micrograms/application nasal spray, suspension
laboratorio aldo-union s.l. baronesa de malda 73, 08950 esplugues de llobregat, barcelona, spain - beclometasone dipropionate - nasal spray, suspension - beclometasone dipropionate 50 µg - nasal preparations
المملكة المتحدة -
الإنجليزية -
MHRA (Medicines & Healthcare Products Regulatory Agency)
qvar 50 autohaler
teva uk ltd - beclometasone dipropionate - pressurised inhalation - 50microgram/1dose
المملكة المتحدة -
الإنجليزية -
MHRA (Medicines & Healthcare Products Regulatory Agency)
qvar 100 inhaler
de pharmaceuticals - beclometasone dipropionate - pressurised inhalation - 100microgram/1dose
المملكة المتحدة -
الإنجليزية -
MHRA (Medicines & Healthcare Products Regulatory Agency)
qvar 50 inhaler
mawdsley-brooks & company ltd - beclometasone dipropionate - pressurised inhalation - 50microgram/1dose
المملكة المتحدة -
الإنجليزية -
MHRA (Medicines & Healthcare Products Regulatory Agency)
qvar 50 inhaler
teva uk ltd - beclometasone dipropionate - pressurised inhalation - 50microgram/1dose
المملكة المتحدة -
الإنجليزية -
MHRA (Medicines & Healthcare Products Regulatory Agency)
qvar 100 autohaler
de pharmaceuticals - beclometasone dipropionate - pressurised inhalation - 100microgram/1dose
إسرائيل -
الإنجليزية -
Ministry of Health
trimbow
kamada ltd, israel - beclometasone dipropionate; formoterol fumarate dihydrate; glycopyrronium as bromide - pressurised solution - glycopyrronium as bromide 9 mcg/delivered dose; formoterol fumarate dihydrate 5.2 mcg/delivered dose; beclometasone dipropionate 87.4 mcg/delivered dose - formoterol, glycopyrronium bromide and beclometasone - copd maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist. asthma maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.…
مالطا -
الإنجليزية -
Malta Medicines Authority
foster 100/6 micrograms per actuation pressurised inhalation solution.
chiesi farmaceutici s.p.a via palermo 26/a, 43122 parma, italy - beclometasone dipropionate, formoterol fumarate, dihydrate - pressurised inhalation, solution - beclometasone dipropionate 100 µg formoterol fumarate dihydrate 6 µg - drugs for obstructive airway diseases
إسرائيل -
الإنجليزية -
Ministry of Health
foster 2006
kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised solution - formoterol fumarate dihydrate 6 mcg/actuation; beclometasone dipropionate anhydrous 200 mcg/actuation - formoterol and beclometasone - foster 200/6 is indicated in the regular treatment of asthma in adults where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.
مالطا -
الإنجليزية -
Malta Medicines Authority
beconase aqueous nasal spray
glaxo wellcome uk limited - beclometasone dipropionate - nasal spray, suspension - beclometasone dipropionate 50 µg - nasal preparations